Current Controversies in the Epidemiology, Diagnosis, and Management of Vaginal Infections

Sponsored by: Roche Molecular Diagnostics

Speaker

Christina A. Muzny, MD, MSPH, FACP

Associate Professor of Medicine and Epidemiology, Division of Infectious Diseases, University of Alabama at Birmingham
BIOGRAPHY

Event Date & Time

DATE: November 21,2018

TIME: 09:00am PST, 12:00pm EST

Abstract

Vaginal infections are a source of considerable morbidity among women. It is estimated that there are more than 10 million office visits per year due to vaginal infections. The three main causes of infectious vaginitis are vulvovaginal candidiasis (VVC), trichomoniasis, and bacterial vaginosis (BV). Each one may cause distressing vaginal symptomatology and the latter two may cause upper genital tract complications. These infections may also contribute to the transmission and acquisition of HIV. This webinar reviews current controversies in the epidemiology, diagnosis, and management of vaginal infections, particularly BV and trichomoniasis. It will include a discussion as to whether or not BV is a sexually transmitted infection, the pathogenesis of incident BV and the role of the BV biofilm, and updated BV treatment recommendations. With regards to trichomonas, the webinar will discuss whether or not it should be a reportable disease, new diagnostic methods, and updated treatment recommendations.

At the end of the webinar, learners should be able to:

Describe the epidemiology of BV, particularly as it relates to sexual transmission
Be knowledgeable on updated treatment options for BV and trichomonas
Be knowledgeable on currently available trichomonas nucleic acid amplification tests